Windlas Biotech Limited (WINDLAS.NS) NSE
Currency In INR
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In INR
| Market Cap | 15.49B |
| Enterprise Value | 15.83B |
| P/E Ratio | 31.66 |
| PEG Ratio | -67.86 |
| Price/Sales Ratio | 2.13 |
| Price/Book Ratio | 3.67 |
| Enterprise/Revenue | 2.18 |
| Enterprise/EBITDA | 18.69 |
| Fiscal Year | March 31, 2026 |
| Most Recent Quarter | September 30, 2026 |
| Profit Margin | 0.07 |
| Operating Margin | 0.08 |
| Return On Assets | 0.07 |
| Return On Equity | 0.12 |
| Revenue | 9.04B |
| Revenue/Share | 476.64 |
| Gross Profit | 1.64B |
| EBITDA | 1.05B |
| Net Income | 664.56M |
| Diluted EPS | 31.15 |
| Total Cash | 2.62B |
| Total Cash/Share | 127.08 |
| Total Debt | 534.29M |
| Total Debt/Equity | 0.09 |
| Current Ratio | 1.66 |
| Book Value Per Share | 275.78 |
| 52-Week Change | 20.76 |
| 52-Week High | 1,181.9 |
| 52-Week Low | 697.4 |
| Moving Average 50 Days | 1,011.78 |
| Moving Average 200 Days | 877.5 |
| Average Volume | 153,204 |
| Shares Outstanding | 20.64M |
| % Held by Institutions | N/A |
| Trailing Annual Dividend Rate | 6.3 |
| Trailing Annual Dividend Yield | 0.62 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |